- increased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- abnormal intestine morphology / MGI
- abnormal small intestine morphology / MGI
- abnormal intestinal mucosa morphology / MGI
- abnormal liver morphology / MGI
- enlarged liver / MGI
- abnormal hepatocyte morphology / MGI
- abnormal adrenal gland morphology / MGI
- abnormal spleen morphology / MGI
- enlarged spleen / MGI
- abnormal choroid plexus morphology / MGI
- abnormal lung morphology / MGI
- decreased body weight / MGI
- abnormal lipid level / MGI
- increased circulating free fatty acid level / MGI
- decreased brown adipose tissue amount / MGI
- decreased white adipose tissue amount / MGI
- lung inflammation / MGI
- emphysema / MGI
- increased circulating insulin level / MGI
- premature death / MGI
- abnormal pulmonary alveolus morphology / MGI
- abnormal type II pneumocyte morphology / MGI
- chronic inflammation / MGI
- hepatic steatosis / MGI
- abnormal brown adipose tissue morphology / MGI
- increased liver weight / MGI
- abnormal duodenum morphology / MGI
- abnormal jejunum morphology / MGI
- increased spleen weight / MGI
- pale kidney / MGI
- insulin resistance / MGI
- abnormal inguinal fat pad morphology / MGI
- abnormal retroperitoneal fat pad morphology / MGI
- increased Clara cell number / MGI
- abnormal interscapular fat pad morphology / MGI
- abnormal small intestinal villus morphology / MGI
- abnormal Kupffer cell morphology / MGI
- abnormal alveolar macrophage morphology / MGI
- enlarged mesenteric lymph nodes / MGI
- absent subcutaneous adipose tissue / MGI
- decreased subcutaneous adipose tissue amount / MGI
- abnormal liver sinusoid morphology / MGI
- increased brown fat cell lipid droplet size / MGI
- abnormal white fat cell size / MGI
- decreased epididymal fat pad weight / MGI
- increased liver triglyceride level / MGI
- increased liver cholesterol level / MGI
- increased type II pneumocyte number / MGI
- increased food intake / MGI
STOCK Lipatm1a(EUCOMM)Hmgu/Biat
Status | Available to order |
EMMA ID | EM:10357 |
International strain name | STOCK Lipatm1a(EUCOMM)Hmgu/Biat |
Alternative name | Stock Lipa |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Lipatm1a(EUCOMM)Hmgu |
Gene/Transgene symbol | Lipa |
Information from provider
Provider | Dagmar Kratky |
Provider affiliation | Institute of Molecular Biology and Biochemistry Center for Molecular Medicine, Medical University of Graz |
Genetic information | Mouse line originates from EUCOMM clone HEPD0960_2_H11 injected into BALB/c blastocysts |
Phenotypic information | Homozygous:unknownHeterozygous:unknown |
References |
|
Homozygous fertile | not known |
Homozygous viable | not known |
Homozygous matings required | no |
Immunocompromised | not known |
Information from EMMA
Archiving centre | University of Veterinary Medicine, Vienna, Austria |
Animals used for archiving | heterozygous C57BL/6N |
Breeding at archiving centre | INFRAFRONTIER-I3 WP8 line produced by ES cell injection at Vetmed. |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Wolman disease / Orphanet_75233
- Cholesteryl ester storage disease / Orphanet_75234
MGI phenotypes (gene matching)
Literature references
- Hepatocyte-specific lysosomal acid lipase deficiency protects mice from diet-induced obesity but promotes hepatic inflammation.;Leopold Christina, Duta-Mare Madalina, Sachdev Vinay, Goeritzer Madeleine, Maresch Lisa Katharina, Kolb Dagmar, Reicher Helga, Wagner Bettina, Stojakovic Tatjana, Ruelicke Thomas, Haemmerle Guenter, Hoefler Gerald, Sattler Wolfgang, Kratky Dagmar, ;2019;Biochimica et biophysica acta. Molecular and cell biology of lipids;1864;500-511; 30639734
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).